Clinical trial
Clarithromycin in Active Crohn's Disease
NCT00269386 · Royal Liverpool University Hospital, Other · Completed
Key facts
| NCT number | NCT00269386 |
|---|---|
| Title | Clarithromycin in Active Crohn's Disease |
| Official title | Randomised Controlled Trial of Clarithromycin in Active Crohn's Disease |
| Lead sponsor | Royal Liverpool University Hospital, Other |
| Collaborators | Abbott Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Crohn's Disease |
| Intervention type | Drug |
| Interventions | Clarithromycin, Placebo |
| Enrollment | 44 |
| Start date | Apr 1, 2000 |
| Primary completion | Dec 1, 2006 |
| Completion | May 1, 2007 |
| First posted | Dec 23, 2005 |
| Last update posted | Jan 7, 2009 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: